戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  in tryptophan and serotonin degradation and mitochondrial dysfunction).
2  microvascular dysfunction and cardiomyocyte/mitochondrial dysfunction).
3 the increase in longevity that is induced by mitochondrial dysfunction.
4 ly associated with a profound and persisting mitochondrial dysfunction.
5 tasis to prevent excess calcium overload and mitochondrial dysfunction.
6 ct abnormalities in neuroimmune processes or mitochondrial dysfunction.
7 ncrease in FA level might be associated with mitochondrial dysfunction.
8 include complex phenotypes, mostly driven by mitochondrial dysfunction.
9 ribed that counter the fatal consequences of mitochondrial dysfunction.
10 ely linked with synaptic damage and synaptic mitochondrial dysfunction.
11 c changes associated with this Abeta-induced mitochondrial dysfunction.
12 vely in telomeres as a direct consequence of mitochondrial dysfunction.
13 levels and improves diseases associated with mitochondrial dysfunction.
14 ng from DNA repair gene dysregulation and/or mitochondrial dysfunction.
15 athway in mitophagy induction in response to mitochondrial dysfunction.
16 d mitochondrial depletion of glutathione and mitochondrial dysfunction.
17 adipocytes were cold sensitive and exhibited mitochondrial dysfunction.
18 ed fusion in a large number of diseases with mitochondrial dysfunction.
19 levels of oxidative stress, thereby inducing mitochondrial dysfunction.
20 inamide adenine dinucleotide, which leads to mitochondrial dysfunction.
21  pharmacological correction of DS-associated mitochondrial dysfunction.
22 reased mitochondrial copy number, and caused mitochondrial dysfunction.
23 in synthesis as a compensatory mechanism for mitochondrial dysfunction.
24 with mitochondria and its absence results in mitochondrial dysfunction.
25 helium and capillary endothelium and induces mitochondrial dysfunction.
26 ure of phagosome physiology with a secondary mitochondrial dysfunction.
27 ng abnormal fatty acid metabolism related to mitochondrial dysfunction.
28 in ubiquitination, antigen presentation, and mitochondrial dysfunction.
29 tabolic reprogramming that leads to platelet mitochondrial dysfunction.
30 anol and tumor necrosis factor alpha-induced mitochondrial dysfunction.
31 NAXD and to link deficient NADHX repair with mitochondrial dysfunction.
32 d that the ammonium-modified Au-NPs elicited mitochondrial dysfunction.
33 sing numbers of diseases are associated with mitochondrial dysfunction.
34 ell, but no therapies are available to treat mitochondrial dysfunction.
35 eased PAR in highly-transcribed regions, and mitochondrial dysfunction.
36 D2 expression causing an increase of ROS and mitochondrial dysfunction.
37 ath worldwide and frequently associated with mitochondrial dysfunction.
38 nes, and subsequent epithelial disorders and mitochondrial dysfunction.
39 y the accumulation of protein aggregates and mitochondrial dysfunction.
40 ed as novel pathomechanisms in diseases with mitochondrial dysfunction.
41 NAFLD has the potential to aggravate hepatic mitochondrial dysfunction.
42 previously linked to impaired glycolysis and mitochondrial dysfunction.
43 , generation of reactive oxygen species, and mitochondrial dysfunction.
44 l mitochondrial content that is reduced upon mitochondrial dysfunction.
45 no protective effect on oligomycin A-induced mitochondrial dysfunction.
46 t ~13 months of age, presumably due to overt mitochondrial dysfunction.
47 renia and bipolar disorder may be linked via mitochondrial dysfunction.
48 ation is a prominent ocular manifestation of mitochondrial dysfunction.
49  in aging yeast leads to iron limitation and mitochondrial dysfunction.
50 pathogenesis, namely inclusion formation and mitochondrial dysfunction.
51  the origins of human disorders arising from mitochondrial dysfunction.
52  and other symptoms, probably all related to mitochondrial dysfunction.
53 lowing chronic stress that are indicative of mitochondrial dysfunction.
54 beneficial outcomes in diseases that involve mitochondrial dysfunction.
55 ied by systemic and central inflammation and mitochondrial dysfunctions.
56 3) induces epigenetic alterations; 4) causes mitochondrial dysfunction; 5) induces oxidative stress;
57 xidative phosphorylation genes indicative of mitochondrial dysfunction (52% of genes in pathway).
58                    Our data demonstrate that mitochondrial dysfunction, a universal feature of human
59  inflammation and oxidative stress, mitigate mitochondrial dysfunction, act as senolytics and impact
60  oxidative stress and cell function, yet how mitochondrial dysfunction affects cell activity and syna
61 acrophages from MPV17(-/-) mice, a model for mitochondrial dysfunction, also showed higher propensity
62               In this context, BRB triggered mitochondrial dysfunction and aberrant cellular energeti
63     Failure to resolve mtDNA breaks leads to mitochondrial dysfunction and affects host cells and tis
64 r neurodegenerative diseases associated with mitochondrial dysfunction and altered ER-Mito interplay.
65 ial impairment is frequently associated with mitochondrial dysfunction and altered neurotransmission.
66  neurodegenerative disorder characterized by mitochondrial dysfunction and an increase in oxidative d
67               Alveolar epithelial cell (AEC) mitochondrial dysfunction and apoptosis are important in
68  higher levels of toxic glucose metabolites, mitochondrial dysfunction and apoptosis.
69                                  Age-related mitochondrial dysfunction and associated oxidative stres
70                                              Mitochondrial dysfunction and cellular stresses activate
71 ranslation, how this process is sensitive to mitochondrial dysfunction and constantly surveyed by rib
72 ge at telomere regions that can be driven by mitochondrial dysfunction and crucially can occur indepe
73 increased cytoplasmic glycogen accumulation, mitochondrial dysfunction and disintegration, and enlarg
74 nflammation and neurodegeneration-associated mitochondrial dysfunction and dynamic abnormalities by n
75       Combined, our results demonstrate that mitochondrial dysfunction and ER stress impaired glutath
76             Perfusion bioreactors attenuated mitochondrial dysfunction and ER stress resulting in a f
77        The Cd exposure caused marked hepatic mitochondrial dysfunction and fatty acid oxidation defic
78 sults in impaired protein import, leading to mitochondrial dysfunction and focal activation of the ca
79 e culture, we found evidence that with aging mitochondrial dysfunction and IL-6 exist in a positive f
80                 Hypercapnic acidosis induces mitochondrial dysfunction and impairs the ability of mes
81 ging phenotypes can be reversed by targeting mitochondrial dysfunction and implicate mitochondrial en
82 ge-dependent exacerbated features, including mitochondrial dysfunction and increased oxidative stress
83 in innate immunity, the relationship between mitochondrial dysfunction and inflammation in heart fail
84  to investigate the mechanistic link between mitochondrial dysfunction and inflammatory activation in
85                                          How mitochondrial dysfunction and its regulation in cancer c
86  treatment reversed metabolic abnormalities, mitochondrial dysfunction and kidney pathology.
87              Impairment of mitophagy induces mitochondrial dysfunction and lipid accumulation, thereb
88 d reveal an important new connection between mitochondrial dysfunction and lysosomal dysregulation in
89 n a possible etiologic or pathogenic role of mitochondrial dysfunction and mitochondrial DNA (mtDNA)
90 uction mediates AILI by promoting hepatocyte mitochondrial dysfunction and necrosis, and suggest that
91 lecular mechanisms that are involved in both mitochondrial dysfunction and neuroinflammation in neuro
92 ue damage, the mTOR/AKT is activated causing mitochondrial dysfunction and p15/16-dependent senescenc
93 al evidence points to an association between mitochondrial dysfunction and Parkinson's disease (PD).
94               Adiponectin deficiency induces mitochondrial dysfunction and promotes endothelial activ
95                                              Mitochondrial dysfunction and proteostasis failure frequ
96 ical and imaging studies and determined that mitochondrial dysfunction and reduced fatty acid oxidati
97                        Loss of Pbp1 leads to mitochondrial dysfunction and reduced fitness during nut
98      PUMA deficiency suppressed APAP-induced mitochondrial dysfunction and release of cell death fact
99  inhibition exacerbated the Mito-FAP-induced mitochondrial dysfunction and sensitized cells to apopto
100                                              Mitochondrial dysfunction and significant changes in met
101 ystem, and its deficiency causes progressive mitochondrial dysfunction and structural abnormalities l
102                          The common cause of mitochondrial dysfunction and structural changes in skel
103         Unfortunately, the ability to assess mitochondrial dysfunction and the efficacy of mitochondr
104                       There is evidence that mitochondrial dysfunction and the innate immune system b
105  mechanism by which EZH2 inhibition leads to mitochondrial dysfunction and the resultant exhaustion.
106 d genes, such as SNCA, LRRK2, and CHCHD2, in mitochondrial dysfunction and their overlap with sporadi
107  bearing only m.3394T>C mutation caused mild mitochondrial dysfunctions and those harboring both m.33
108 s of function does not underlie the observed mitochondrial dysfunction, and also provides a mechanism
109 cence-associated secretory phenotype (SASP), mitochondrial dysfunction, and alterations in DNA and ch
110 active oxygen species (ROS) in the placenta, mitochondrial dysfunction, and disturbed superoxide dism
111 ls exhibited a basal elevated MitoROS level, mitochondrial dysfunction, and enhanced stress response
112 ng axonal and vascular injury, metabolic and mitochondrial dysfunction, and glial reactivity.
113 mall adipocytes, activation of immune cells, mitochondrial dysfunction, and impaired metabolism toget
114 ects, these drugs promoted oxidative stress, mitochondrial dysfunction, and insulin resistance.
115 ted that OPN blockade reversed hypertension, mitochondrial dysfunction, and kidney failure in Col4a3(
116 ns and stressors, impaired immune responses, mitochondrial dysfunction, and neuroinflammation.
117  the key genes involving cell cycle control, mitochondrial dysfunction, and oxidative phosphorylation
118 crease in aortic IL-6 and Parkin, attenuated mitochondrial dysfunction, and reduced atherogenesis.
119 ce toward sympathetic dominance, and cardiac mitochondrial dysfunction, and reduced the number of act
120 reased apoptosis, oxidative stress, signs of mitochondrial dysfunction, and reduced transcription of
121  mineralization, cytoskeletal rearrangement, mitochondrial dysfunction, and reduced type 1 collagen s
122  disrupts retinal bioenergetics resulting in mitochondrial dysfunction, and retinal degeneration and
123 d consistent enrichment in oxidative stress, mitochondrial dysfunction, and transcription initiation
124                     However, the severity of mitochondrial dysfunction, and/or the specific mitochond
125 tions resulting in aberrant gene expression, mitochondrial dysfunctions, and enhanced hepatic glucone
126 es including ER stress, defective autophagy, mitochondrial dysfunction, apoptosis, inflammatory cell
127                                              Mitochondrial dysfunctions appear also involved in ASD p
128 r grafts have not been fully elucidated, but mitochondrial dysfunction appears to be contributory.
129 idation, mitochondrial calcium overload, and mitochondrial dysfunction are characteristics of dysfunc
130 her derailments in fatty acid metabolism and mitochondrial dysfunction are forerunners of tubular dam
131           Fatty liver, oxidative stress, and mitochondrial dysfunction are key pathophysiological fea
132      We review and evaluate the evidence for mitochondrial dysfunction as a consequence of stress exp
133                              Our data unveil mitochondrial dysfunction as a contributor to the impair
134 in both flies and human neurons, implicating mitochondrial dysfunction as a mechanism in biotin defic
135  response (UPR(mt)) to detect and respond to mitochondrial dysfunction as an indicator of infection.
136                    Despite this, the role of mitochondrial dysfunction as an initiator, propagator, o
137              This study explores the role of mitochondrial dysfunction as an intramuscular signal for
138             In addition, TTNtv hearts showed mitochondrial dysfunction, as evidenced by decreased oxy
139 nal regulation of iron metabolism genes, and mitochondrial dysfunction, as observed in the mouse mode
140 4T>C mutation-induced alterations aggravated mitochondrial dysfunctions associated with the m.11778G>
141 ed to elevated IL (interleukin)-6 levels and mitochondrial dysfunction, associated with increased mit
142 e potential, even under conditions of severe mitochondrial dysfunction, but triggers a detrimental im
143  in the context of diabetes could accelerate mitochondrial dysfunction by disrupting protective metab
144 g mechanism was the induction of hippocampal mitochondrial dysfunction by neonatal hyperoxia.
145      Under conditions of inherent or induced mitochondrial dysfunction, cancer cells manifest overlap
146                                              Mitochondrial dysfunction causes Ca(2+) overload and ECM
147 rane function, endoplasmic reticulum stress, mitochondrial dysfunction, cell death, and inflammation.
148 pigenetic alterations, loss of proteostasis, mitochondrial dysfunction, cellular senescence, deregula
149 tion and regulation of cell viability, while mitochondrial dysfunction characterizes heart failure.
150 o have important implications for studies of mitochondrial dysfunction conducted in mouse models of f
151 d to determine whether mitochondrial DNA and mitochondrial dysfunction contribute to the pathogenesis
152                                              Mitochondrial dysfunction contributes to heart failure i
153                                              Mitochondrial dysfunction contributes to hypertension, b
154                                              Mitochondrial dysfunction could alter the redox state an
155 irment of autophagic degradation process and mitochondrial dysfunction data were confirmed in vitro u
156 Tat-Beclin1) activated mitophagy, attenuated mitochondrial dysfunction, decreased lipid accumulation,
157 in-treated pregnant rats was associated with mitochondrial dysfunction, disturbed superoxide dismutas
158  links extracellular inflammatory signals to mitochondrial dysfunction during AKI partly via PPARGC1A
159 ific manner and is mechanistically linked to mitochondrial dysfunction, endoplasmic reticulum (ER) st
160                                         Upon mitochondrial dysfunction, EOL-1 is concentrated into fo
161      However, the exact pathological role of mitochondrial dysfunction, especially in mitochondrial r
162 e in potassium homeostasis, which led to the mitochondrial dysfunction followed by an acute inflammat
163 control animals, it significantly attenuated mitochondrial dysfunction following SCI.
164      A large body of evidence indicates that mitochondrial dysfunction has a major role in the pathog
165                                              Mitochondrial dysfunction has been associated with neuro
166                                              Mitochondrial dysfunction has been associated with sever
167                                              Mitochondrial dysfunction has been implicated in many pa
168 ected in vivo In key metabolic tissues where mitochondrial dysfunction has been implicated in T2D dev
169 s in age-related macular degeneration, where mitochondrial dysfunction has been implicated in the pat
170                                              Mitochondrial dysfunction has been implicated in the pat
171                                              Mitochondrial dysfunction has been proposed as a key eve
172                                              Mitochondrial dysfunction has been recognized as an esse
173                                     Although mitochondrial dysfunction has been suggested in RTT, les
174                                              Mitochondrial dysfunction has consequences not only for
175                                              Mitochondrial dysfunction has long been implicated in th
176 he unique and critical impact that adipocyte mitochondrial dysfunction has on increasing beta-cell ma
177                          Numerous studies of mitochondrial dysfunction have been conducted using mous
178                Mechanisms of neuroimmune and mitochondrial dysfunction have been repeatedly implicate
179 eviates, respectively, high-fat diet-induced mitochondrial dysfunction, hepatosteatosis, and insulin
180  Our results implicated oxidative stress and mitochondrial dysfunction, hormone level elevations, lip
181                                  MMS-induced mitochondrial dysfunction, however, is AAG-independent.
182  alpha-synuclein misfolding and aggregation, mitochondrial dysfunction, impairment of protein clearan
183                                              Mitochondrial dysfunction impairs muscle health and caus
184                                 We show that mitochondrial dysfunction impairs translational terminat
185 rcise-training programme on these aspects of mitochondrial dysfunction in a NDD-CKD cohort.For the co
186  Consistently, mTORC1 inhibition ameliorates mitochondrial dysfunction in a neuronal model of NPC.
187 viously modeled amyloid-beta (Abeta)-induced mitochondrial dysfunction in a transgenic Caenorhabditis
188 increase in oxidative stress associated with mitochondrial dysfunction in adipocytes.
189 for other studies aimed at understanding RPE mitochondrial dysfunction in aging and disease.
190             However, given the major role of mitochondrial dysfunction in AKI, there is a need to rep
191 ion data suggested the presence of extensive mitochondrial dysfunction in ATAA tissues.
192            This study is the first to assess mitochondrial dysfunction in brain and muscle in individ
193                         Here, we report that mitochondrial dysfunction in Caenorhabditis elegans acti
194 cts were recognized as potential markers for mitochondrial dysfunction in conjunction with age relate
195  both sexes with genetically induced, severe mitochondrial dysfunction in DaNs (MitoPark mice), at th
196 he relationship between glucose delivery and mitochondrial dysfunction in diabetic cardiomyopathy, we
197 s triggered mitochondrial calcium influx and mitochondrial dysfunction in endothelial cells, and 12(S
198 st that CHCHD10 restoration could ameliorate mitochondrial dysfunction in FTLD-TDP.
199 ys that govern IL6 production in response to mitochondrial dysfunction in GRSF1-depleted cells.
200 conclusion that mitochondrial biogenesis and mitochondrial dysfunction in LAM cells provide a novel t
201                               To investigate mitochondrial dysfunction in MSA further we examined ETC
202                        This study highlights mitochondrial dysfunction in MSA pathogenesis, suggests
203 icient in MSA brain tissue, thus implicating mitochondrial dysfunction in MSA.
204 loring the mechanistic role of developmental mitochondrial dysfunction in neurodevelopmental, psychia
205 ic, and clinical evidence for apoptosome and mitochondrial dysfunction in prostate cancer racial disp
206 n shown to play a critical role in mediating mitochondrial dysfunction in response to reactive oxygen
207 endoplasmic reticulum stress, autophagy, and mitochondrial dysfunction in the acinar cells are now re
208 etion of DDX5 resulted in reduced growth and mitochondrial dysfunction in the chemoresistant SCLC cel
209 ced superoxide production is associated with mitochondrial dysfunction in the kidneys of mouse models
210 mans, and the evidence supporting a role for mitochondrial dysfunction in the pathophysiology of HFpE
211 argetable pathways, whose modulation repairs mitochondrial dysfunctions in patient-derived cells and
212 letion in cells was reflected in severity of mitochondrial dysfunction, including respiratory efficie
213 vernutrition worsened excitotoxicity-induced mitochondrial dysfunction, increasing metabolic inflexib
214        We further show that NNT loss elicits mitochondrial dysfunction independent of substantial inc
215         Interestingly, these cells exhibited mitochondrial dysfunction, indicated by reactive oxygen
216 norganic nitrate prevents aspects of cardiac mitochondrial dysfunction induced by hypoxia, although t
217                                  Conversely, mitochondrial dysfunction-induced glutathione oxidation
218  its downstream detrimental effects, such as mitochondrial dysfunction, inflammation, and fibrosis.
219  hypoxia and can result in oxidative stress, mitochondrial dysfunction, inflammation, and overactivat
220 er time course, provided that RGC death from mitochondrial dysfunction is a cell-autonomous process.
221                                              Mitochondrial dysfunction is a hallmark of amyloid-beta
222 nt neurological deficits is not fully known, mitochondrial dysfunction is a key component in methamph
223                                              Mitochondrial dysfunction is an important cause of herit
224                                      Primary mitochondrial dysfunction is an under-appreciated cause
225                                              Mitochondrial dysfunction is associated with a spectrum
226                                              Mitochondrial dysfunction is associated with activation
227 th high energy demand such as the heart, and mitochondrial dysfunction is associated with cardiovascu
228                                              Mitochondrial dysfunction is critically involved in Park
229         Therefore, our results indicate that mitochondrial dysfunction is downstream of lysosomal alk
230                               Adipose tissue mitochondrial dysfunction is emerging as a key component
231 es the risk of Alzheimer's disease (AD), and mitochondrial dysfunction is implicated in both diseases
232 l of rotator cuff disease, we tested whether mitochondrial dysfunction is implicated in muscle wastin
233                                              Mitochondrial dysfunction is implicated in sporadic and
234 ion to amyloid-beta plaques and tau tangles, mitochondrial dysfunction is implicated in the pathology
235 a are the main source of cellular energy and mitochondrial dysfunction is implicated in the pathology
236 nction and viability of eukaryotic cells and mitochondrial dysfunction is involved in the pathogenesi
237                                              Mitochondrial dysfunction is involved in the pathology o
238 compared with Parkinson's disease (PD) where mitochondrial dysfunction is known to be important.
239                   Enhanced RNAi triggered by mitochondrial dysfunction is necessary for the increase
240                                              Mitochondrial dysfunction is postulated to be central to
241        Mitochondrial aging, which results in mitochondrial dysfunction, is strongly linked to many ag
242 ating mtDNA in human blood as a biomarker of mitochondrial dysfunction, it is important to measure bo
243 , increasing insulin sensitivity, correcting mitochondrial dysfunction, ketone-based interventions, a
244 d in mice results in genomic instability and mitochondrial dysfunction, leading to a dramatic multi-s
245 p early-onset optic atrophy, severe systemic mitochondrial dysfunction leads to very early death and
246                                        Brain mitochondrial dysfunction limits neurologic recovery aft
247 paired insulin secretion in conjunction with mitochondrial dysfunction, loss of protection against ox
248  treatment reduces Abeta production, reduces mitochondrial dysfunction, maintains mitochondrial dynam
249      Perhaps paradoxically, certain forms of mitochondrial dysfunction may best be buffered with "sec
250 drial fitness, rather than target downstream mitochondrial dysfunction, may aid in the search for the
251 gs of this study provide novel evidence that mitochondrial dysfunction measured in peripheral blood i
252 stered to patients with primary or secondary mitochondrial dysfunction, might be due to its function
253 those involved in oxidative phosphorylation, mitochondrial dysfunction, nutrient metabolism, cardiac
254                                              Mitochondrial dysfunction, often based on inherited gene
255                                              Mitochondrial dysfunction or loss is evident in neurodeg
256 rix remodelling, transcriptional regulation, mitochondrial dysfunction, oxidative stress, calcium and
257                                     Although mitochondrial dysfunction plays a key role in the pathop
258 t dysbiosis, inflammation, oxidative stress, mitochondrial dysfunction, premature ageing and epigenet
259 reas, excessive intracellular calcium causes mitochondrial dysfunction, premature zymogen activation,
260            Among these, lipid metabolism and mitochondrial dysfunction proteins were overrepresented.
261              Our data suggest that sustained mitochondrial dysfunction, rather than atrophy alone, un
262 MYCN levels promote metabolic reprogramming, mitochondrial dysfunction, reactive-oxygen species gener
263 hanisms that impair homeostatic responses to mitochondrial dysfunction remain unclear.
264  complication of liver surgery that involves mitochondrial dysfunction resulting from mitochondrial p
265 hronic low level exposures in adults lead to mitochondrial dysfunction, severe damage to glial cells,
266                       At the cellular level, mitochondrial dysfunction starts at the synapses, then i
267 3 kinase-mTOR signaling, impaired autophagy, mitochondrial dysfunction, stem cell exhaustion, epigene
268 ion of RCD1 leads to increased expression of mitochondrial dysfunction stimulon (MDS) genes regulated
269         They include mechanisms dependent on mitochondrial dysfunction such as DOX influence on the m
270 s, and mutations in BOLA3 result in multiple mitochondrial dysfunction syndrome, a fatal disorder ass
271 in the pathogenesis of the disease, multiple mitochondrial dysfunctions syndrome.
272               Reactive oxygen species (ROS), mitochondrial dysfunction, telomere shortening, genomic
273 C and m.11778G>A mutations exhibited greater mitochondrial dysfunctions than cybrids carrying only m.
274 , there was an inherent state of endothelium mitochondrial dysfunction that could contribute to endot
275 metabolite regulation, oxidative stress, and mitochondrial dysfunction that has direct implications f
276 is results in deleterious effects, including mitochondrial dysfunction, that contribute to pathophysi
277 inflammation, oxidative stress, epigenetics, mitochondrial dysfunction, the gut microbiota, tryptopha
278 diated caspase activation and contributes to mitochondrial dysfunction, thereby promoting therapeutic
279 ts impairment of mitochondrial transport and mitochondrial dysfunction through a mechanism involving
280 rders, have been shown to be associated with mitochondrial dysfunction through multiple molecular mec
281 id accumulation can promote lipotoxicity and mitochondrial dysfunction, thus triggering hepatocyte de
282  trace mechanisms linking different forms of mitochondrial dysfunction to the ISR in proliferating mo
283 spels the notion of a universal path linking mitochondrial dysfunction to the ISR, instead revealing
284                                 Due to their mitochondrial dysfunction, TOP1MT-KO cells become addict
285                          In mammalian cells, mitochondrial dysfunction triggers the integrated stress
286                                              Mitochondrial dysfunction underlies many heritable disea
287                    It has been proposed that mitochondrial dysfunction underlies neuronal damage, the
288                         Studies suggest that mitochondrial dysfunction underlies some forms of sepsis
289                                              Mitochondrial dysfunction underlies the etiology of a br
290 turbation of CBS/H(2) S activity could drive mitochondrial dysfunction via mitochondrial dynamics in
291                       Glomerular endothelial mitochondrial dysfunction was associated with increased
292 otypes resemble mitochondrial disorders, and mitochondrial dysfunction was first observed in ADCA-DN.
293                                              Mitochondrial dysfunction was highlighted as a crucial v
294 anisms underlying APOL1 risk variant-induced mitochondrial dysfunction, we generated tetracycline-ind
295             To identify pathways that modify mitochondrial dysfunction, we performed genome-wide CRIS
296 the acquisition of glycolytic phenotypes and mitochondrial dysfunction, whereas cytochrome c restorat
297         Deficiencies in such systems lead to mitochondrial dysfunction, which is a hallmark of aging
298 ablate a number of these genes and result in mitochondrial dysfunction, which is associated with bona
299 ses a severe neurodevelopmental delay due to mitochondrial dysfunction with complex I impairments and
300 inal extension), which mechanistically links mitochondrial dysfunction with proteostasis failure.

 
Page Top